Related Experiment Video
Updated: Jun 3, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Alexithymia in neurodegenerative disease
Virginia E Sturm1, Robert W Levenson
1Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
Neurocase
|March 25, 2011
Summary
This study found higher alexithymia, or difficulty identifying emotions, in neurodegenerative disease patients compared to controls. Alexithymia correlated with behavioral issues and reduced gray matter volume in a key brain region for emotion processing.
Area of Science:
- Neuroscience
- Psychiatry
Background:
- Alexithymia is a deficit in identifying and describing emotions.
- Neurodegenerative diseases can impact emotional processing and behavior.
Purpose of the Study:
- To investigate alexithymia levels in neurodegenerative disease patients versus healthy controls.
- To examine the relationship between alexithymia, behavioral disturbances, and brain structure.
Main Methods:
- Alexithymia assessed using the Toronto Alexithymia Scale-20.
- Behavioral disturbance measured with the Neuropsychiatric Inventory.
- Regional gray matter volumes analyzed from structural MRI scans.
Main Results:
- Patients with neurodegenerative disease exhibited higher alexithymia scores than controls.
- Alexithymia positively correlated with apathy and informant distress.
- Alexithymia negatively correlated with gray matter volume in the right pregenual anterior cingulate cortex.
Conclusions:
- Neurodegenerative disease is associated with increased alexithymia.
- Alexithymia is linked to specific behavioral disturbances and structural brain changes in this population.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...